HC Wainwright Decreases Earnings Estimates for Altimmune
Altimmune, Inc. (NASDAQ:ALT – Free Report) – Research analysts at HC Wainwright lowered their FY2029 EPS estimates for shares of Altimmune in a report released on Thursday, May 22nd. HC Wainwright analyst P. Trucchio now expects that the company will post earnings of $1.22 per share for the year, down from their prior forecast of […]
